What is the difference between ALPRAZOLAM and ALPRAZOLAM ODT C-IV?

ALPRAZOLAM and ALPRAZOLAM ODT C-IV are both Benzodiazepines, so they work through the same broad mechanism. They differ in dosing, half-life, side-effect frequency, and how individual patients tolerate them. See the head-to-head sections below for the specifics.

Is Alprazolam the same as Alprazolam ODT C-IV?

No. Alprazolam (ALPRAZOLAM) and Alprazolam ODT C-IV (ALPRAZOLAM ODT C-IV) are distinct medications. They are sometimes confused because of similar branding or because they treat overlapping conditions, but they have different active ingredients and different safety profiles.

Which has fewer side effects, ALPRAZOLAM or ALPRAZOLAM ODT C-IV?

Side-effect frequency varies by individual. The side-effect comparison section on this page shows FAERS-reported events for each drug side by side. FAERS is voluntary reporting, so it reflects what patients and clinicians chose to report, not absolute population risk.

Can I switch from ALPRAZOLAM to ALPRAZOLAM ODT C-IV?

Switching medications should always be done under prescriber supervision. The "patient stories" section on this page includes accounts from people who have made the switch and what their transition felt like, but those are individual experiences, not protocols.

ALPRAZOLAM vs ALPRAZOLAM ODT C-IV

Compare ALPRAZOLAM (Alprazolam) and ALPRAZOLAM ODT C-IV (Alprazolam ODT C-IV) — clinical data, side effects, and patient experiences.

ALPRAZOLAM

Alprazolam, Xanax · Benzodiazepine

How it works

12.1 Mechanism of Action Alprazolam is a 1,4 benzodiazepine. Alprazolam exerts its effect for the acute treatment of generalized anxiety disorder and panic disorder through binding...

Approved for

1 INDICATIONS AND USAGE Alprazolam tablets are indicated for the: acute treatment of generalized anxiety disorder (GAD) in adults. treatment of panic disorder (PD)

OralTablet

ALPRAZOLAM ODT C-IV

Alprazolam ODT C-IV · Benzodiazepine

How it works

Benzodiazepine agent

Approved for

1.1 Generalized Anxiety Disorder Alprazolam orally disintegrating tablets

USP are indicated for the treatment of generalized anxiety disorder. The efficacy of alprazolam in the treatment of generalized anxiety disorder was demonstrated in 5 short-term

placebo-controlled trials [see Clinical Studies (14.1)]. 1.2 Panic Disorder Alprazolam orally disintegrating tablets

USP are also indicated for the treatment of panic disorder

OralTablet

Quick Comparison

ALPRAZOLAMALPRAZOLAM ODT C-IV

Drug Class

Benzodiazepine

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

ALPRAZOLAM

Drug Not Working

1-10%

Nausea

1-10%

Fatigue

1-10%

Anxiety

1-10%

Headache

1-10%

Diarrhea

1-10%

Shortness of Breath

1-10%

Dizziness

1-10%

ALPRAZOLAM ODT C-IV

Drug Not Working

1-10%

Nausea

1-10%

Fatigue

1-10%

Anxiety

1-10%

Headache

1-10%

Diarrhea

1-10%

Shortness of Breath

1-10%

Dizziness

1-10%

FDA Warnings

ALPRAZOLAM

5 WARNINGS AND PRECAUTIONS Effects on Driving and Operating Machinery: Patients receiving alprazolam should be cautioned against operating machinery or driving a motor vehicle, as well as avoiding concomitant use of alcohol and other central nervous system (CNS) depressant drugs
1 Risks from Concomitant Use with Opioids Concomitant use of benzodiazepines, including alprazolam, and opioids may result in profound sedation, respiratory depression, coma, and death
Because of these risks, reserve concomitant prescribing of these drugs in patients for whom alternative treatment options are inadequate
Observational studies have demonstrated that concomitant use of opioid analgesics and benzodiazepines increases the risk of drug-related mortality compared to use of opioids alone

ALPRAZOLAM ODT C-IV

1 Risks from Concomitant Use with Opioids Concomitant use of benzodiazepines, including alprazolam, and opioids may result in profound sedation, respiratory depression, coma, and death
Because of these risks, reserve concomitant prescribing of these drugs in patients for whom alternative treatment options are inadequate
Observational studies have demonstrated that concomitant use of opioid analgesics and benzodiazepines increases the risk of drug-related mortality compared to use of opioids alone
Advise both patients and caregivers about the risks of respiratory depression and sedation when alprazolam is used with opioids

Clinical Trial Data

No head-to-head clinical studies found for ALPRAZOLAM vs ALPRAZOLAM ODT C-IV.

ALPRAZOLAM vs ALPRAZOLAM ODT C-IV: What You Should Know

Key Differences

Both ALPRAZOLAM and ALPRAZOLAM ODT C-IV belong to the Benzodiazepine class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients.

Safety Considerations

ALPRAZOLAM carries 4 FDA warnings. ALPRAZOLAM ODT C-IV carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

ALPRAZOLAM vs LORAZEPAM→ALPRAZOLAM vs CLONAZEPAM→ALPRAZOLAM vs DIAZEPAM→ALPRAZOLAM vs OXAZEPAM→ALPRAZOLAM vs TEMAZEPAM→ALPRAZOLAM vs CLOBAZAM→

Primary sources

Every figure on this comparison links back to its primary source. See data sources and methodology for the full provenance trail.

ALPRAZOLAM: DailyMed label · FAERS adverse events · ClinicalTrials.gov
ALPRAZOLAM ODT C-IV: DailyMed label · FAERS adverse events · ClinicalTrials.gov

Loading comparison data...

ALPRAZOLAM vs ALPRAZOLAM ODT C-IV

Compare ALPRAZOLAM (Alprazolam) and ALPRAZOLAM ODT C-IV (Alprazolam ODT C-IV) — clinical data, side effects, and patient experiences.

ALPRAZOLAM

Alprazolam, Xanax · Benzodiazepine

How it works

12.1 Mechanism of Action Alprazolam is a 1,4 benzodiazepine. Alprazolam exerts its effect for the acute treatment of generalized anxiety disorder and panic disorder through binding...

Approved for

1 INDICATIONS AND USAGE Alprazolam tablets are indicated for the: acute treatment of generalized anxiety disorder (GAD) in adults. treatment of panic disorder (PD)

OralTablet

ALPRAZOLAM ODT C-IV

Alprazolam ODT C-IV · Benzodiazepine

How it works

Benzodiazepine agent

Approved for

1.1 Generalized Anxiety Disorder Alprazolam orally disintegrating tablets

USP are indicated for the treatment of generalized anxiety disorder. The efficacy of alprazolam in the treatment of generalized anxiety disorder was demonstrated in 5 short-term

placebo-controlled trials [see Clinical Studies (14.1)]. 1.2 Panic Disorder Alprazolam orally disintegrating tablets

USP are also indicated for the treatment of panic disorder

OralTablet

Quick Comparison

ALPRAZOLAMALPRAZOLAM ODT C-IV

Drug Class

Benzodiazepine

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

ALPRAZOLAM

Drug Not Working

1-10%

Nausea

1-10%

Fatigue

1-10%

Anxiety

1-10%

Headache

1-10%

Diarrhea

1-10%

Shortness of Breath

1-10%

Dizziness

1-10%

ALPRAZOLAM ODT C-IV

Drug Not Working

1-10%

Nausea

1-10%

Fatigue

1-10%

Anxiety

1-10%

Headache

1-10%

Diarrhea

1-10%

Shortness of Breath

1-10%

Dizziness

1-10%

FDA Warnings

ALPRAZOLAM

5 WARNINGS AND PRECAUTIONS Effects on Driving and Operating Machinery: Patients receiving alprazolam should be cautioned against operating machinery or driving a motor vehicle, as well as avoiding concomitant use of alcohol and other central nervous system (CNS) depressant drugs
1 Risks from Concomitant Use with Opioids Concomitant use of benzodiazepines, including alprazolam, and opioids may result in profound sedation, respiratory depression, coma, and death
Because of these risks, reserve concomitant prescribing of these drugs in patients for whom alternative treatment options are inadequate
Observational studies have demonstrated that concomitant use of opioid analgesics and benzodiazepines increases the risk of drug-related mortality compared to use of opioids alone

ALPRAZOLAM ODT C-IV

1 Risks from Concomitant Use with Opioids Concomitant use of benzodiazepines, including alprazolam, and opioids may result in profound sedation, respiratory depression, coma, and death
Because of these risks, reserve concomitant prescribing of these drugs in patients for whom alternative treatment options are inadequate
Observational studies have demonstrated that concomitant use of opioid analgesics and benzodiazepines increases the risk of drug-related mortality compared to use of opioids alone
Advise both patients and caregivers about the risks of respiratory depression and sedation when alprazolam is used with opioids

Clinical Trial Data

No head-to-head clinical studies found for ALPRAZOLAM vs ALPRAZOLAM ODT C-IV.

ALPRAZOLAM vs ALPRAZOLAM ODT C-IV: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.